Provident Bancorp In
Provident Bancorp Investor Alert: Kaplan Fox Investigates Provident Bancorp
25 nov. 2022 11h56 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Provident Bancorp, Inc. (“Provident” or “Company”)...
Kaplan Fox Continues
Kaplan Fox Continues to Investigate Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) - INVESTOR UPDATE
25 nov. 2022 10h59 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing to investigate claims on behalf of investors in Spectrum Pharmaceuticals, Inc....
DLocal Limited Share
DLocal Limited Shareholder Alert: Kaplan Fox is Investigating Potential Securities Fraud (DLO)
23 nov. 2022 16h59 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DLocal Limited (“DLocal”) (NASDAQ: DLO). If you...
Kaplan Fox Investiga
Kaplan Fox Investigates Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
21 nov. 2022 18h16 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...
FIGS INVESTOR ALERT:
FIGS INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies FIGS Investors of a Class Action Lawsuit and Upcoming Deadline
16 nov. 2022 13h45 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of FIGS Inc. (NYSE: FIGS).  A class action complaint...
SPPI Investor Alert:
SPPI Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Spectrum Pharmaceuticals, Inc.
11 nov. 2022 20h00 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...
FRESHWORKS INVESTOR
FRESHWORKS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Freshworks Investors of a Class Action Lawsuit and Upcoming Deadline
10 nov. 2022 17h54 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.Kaplanfox.com) is investigating claims on behalf of investors of Freshworks Inc. (NASDAQ: FRSH).  A class action...
Fulgent Genetics’s I
Fulgent Genetics’s Investor Alert: Kaplan Fox Reminds Investors of an Important Deadline
09 nov. 2022 11h35 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a securities class action case has been brought against Fulgent Genetics, Inc....
Y-mAbs Therapeutics,
Y-mAbs Therapeutics, Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Fraud
04 nov. 2022 09h00 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the...
Spectrum Pharmaceuti
Spectrum Pharmaceuticals, Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Fraud
03 nov. 2022 17h16 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...